Licorice Poisoning


Practice Essentials

 Natural licorice is an extract from the root of Glycyrrhiza glabra, a 4- to 5-foot woody shrub that contains glycyrrhizic acid (GZA) and grows in subtropical climates in Europe, the Middle East, and Western Asia. Licorice extracts and its principal component, glycyrrhizin, have extensive use in foods, tobacco products, and snuff, and in traditional and herbal medicine.

As a result of these extensive applications, estimated consumption of licorice and glycyrrhizin in the United States is high: 0.027-3.6 mg glycyrrhizin per kilograms per day.[1] However, many candies marketed as licorice (eg, red licorice) have artificial licorice flavoring and do not contain glycyrrhizin.[2]   Licorice root that is sold as a dietary supplement can be found with the glycyrrhizin removed, resulting in a product known as deglycyrrhizinated licorice, or DGL.[3]

Licorice poisoning is rare. However, regular licorice ingestion can result in hypokalemia, hypernatremia, and water retention (see Presentation and Workup). Emergency treatment of licorice poisoning is largely supportive and consists primarily of monitoring for electrolyte abnormalities (especially of potassium) and other complications, with correction if necessary (see Treatment).


Licorice (or liquorice) is a plant of ancient origin and steeped in history. Licorice has been used as a medicinal agent in a number of cultures,[4] dating back to ancient Egypt and China. Medicinal uses have included the following:

Licorice flavor is found in a wide variety of licorice candies. Licorice is also found in some soft drinks (eg, root beer) and is in some herbal teas where it provides a sweet aftertaste.[12]

 Licorice extract (block, powder, or liquid) may be applied to cigarette tobacco at levels of about 1-4% to enhance and harmonize the flavor characteristics of smoke, improve moisture-holding characteristics of tobacco, and act as a surface-active agent for ingredient application.[13]



Natural licorice possesses both mineralocorticoid properties and glucocorticoid properties. Most licorice-flavored foods available in the United States do not contain GZA, and they do not produce the hypermineralocorticoid syndromes observed with the long-term consumption of moderate-to-significant amounts of natural licorice.

Consumption of large doses of GZA in licorice extract can lead to hypokalemia and serious hypertension, a syndrome known as hypermineralocorticoidism.[14, 15] Biochemical studies indicate that glycyrrhizinates inhibit 11-beta-hydroxysteroid dehydrogenase (type 2), the enzyme responsible for inactivating cortisol through conversion to cortisone. As a result, a continuous, high-level exposure to glycyrrhizin compounds can produce hypermineralocorticoid-like effects in both animals and humans. These effects are reversible upon withdrawal of licorice or glycyrrhizin.[1]

In the kidney, cortisol activation of mineralocorticoid receptors alters renal tubular exchange of sodium (retained), potassium (excreted), and hydrogen ions (excreted); producing an increased extracellular volume (hypertension,[16] edema), hypokalemia (weakness, muscle spasm),[17] and metabolic alkalosis.[18]

Pseudoprimary aldosteronism from chronic licorice ingestion is characterized by low serum and urinary aldosterone levels and decreased serum renin activity. This differs from true primary hyperaldosteronism caused by aldosterone-producing adenomas or primary adrenal hyperplasia, which is characterized by elevated urine and serum aldosterone levels.

Licorice can reduce the serum testosterone level, probably by blocking 17-hydroxysteroid dehydrogenase and 17,20 lyase.[19] Licorice has therefore been considered an adjuvant therapy of hirsutism and polycystic ovary syndrome.[20]

The exact amount of ingested GZA that produces mineralocorticoid toxicity is unclear. A meta-analysis to assess the effect of chronic ingestion of licorice found the mean daily dose of glycyrrhizic acid across 18 studies was 377.9 mg, which is approximately 189 g of black licorice a day, assuming 2.0 mg g−1 (0.2% w/w) glycyrrhizic acid in black licorice. However, the concentration of glycyrrhizic acid changes significantly dependent on the product. Licorice findings range between 0.26 and 7.9 mg g−1, while in health products the range was 0.30 to 7.9 mg g−1. A typical pack of Liquorice Allsorts was found to contain 91.0 mg, a serving of licorice tea contained 20.0 mg and a single licorice pipe contained 4.6 mg. With only limited and sporadic consumption of licorice, it would be difficult to ingest more than 500 mg of glycyrrhizic acid per day. Assuming an average concentration of 2.0 mg g−1 for black licorice confectionery, it would require consumption of 250 g per day to reach 500 mg of glycyrrhizic acid daily. While this quantity is relatively high, but as evidenced by numerous case reports, a small portion of the population does consume licorice at these levels.[21]


Patients generally fully recover with discontinuation of exposure. After licorice exposure is discontinued, spontaneous correction of hypertension and hypokalemia generally occur within several weeks; however, months may pass before the renin-aldosterone system becomes active again.[22] Muscle weakness/paralysis may resolve within days of potassium replacement.

Severe, and sometimes fatal, complications following ingestion of licorice can occur. In these cases, significant quantities of licorice have typically been consumed in the short- to medium-term. Reported complications include rhabdomyolysis, hypertensive encephalopathy and cardiac arrest and death.[21]


Most patients with licorice poisoning report chronic toxicity from daily excessive ingestion of natural licorice products (not artificial licorice flavoring). Cases of poisoning are mostly chronic in nature, not acute; however, binging on licorice has also resulted in toxicity.[2] Symptoms of licorice toxicity may include the following:

Physical Examination

Findings on physical examination may include the following:

Approach Considerations

Diagnosis is generally confirmed by combination of hypokalemia, increased urinary free cortisol, elevated cortisol-cortisone metabolite ratio, and low or absent urinary aldosterone. A low serum potassium level is the most helpful screening result for establishing mineralocorticoid excess in patients with hypertension. An elevated urinary potassium level may be present. Dilutional anemia may be present, and the hematocrit may be depressed. Hypokalemia, hypernatremia, and water retention are primary problems associated with chronic licorice ingestion.[2]

Licorice poisoning can cause hypokalemic rhabdomyolysis with resultant myoglobinuria and elevated serum creatine kinase level.[28, 29] Myoglobinuria can cause acute tubular necrosis. Emergency physicians should inquire about the consumption of products that may contain natural licorice extract when patients present with unexplained hypertension, hypokalemia, edema, rhabdomyolysis, or myoglobinuria.[30]

If clinically indicated, chest radiography may be performed to assess for pulmonary edema. If urine aldosterone levels are high in a patient with evidence of hypermineralocorticoidism (eg, hypertension, hypokalemia, suppression of the renin-angiotensin system), tumors rather than chronic licorice toxicity are more likely to be the cause, and abdominal computed tomography or magnetic resonance imaging scans may be warranted.

Electrocardiography should be performed to evaluate for hypokalemic changes and QT prolongation or dysrhythmia, including torsades des pointes. Pulse oximetry and arterial blood gas (ABG) measurement can be used to evaluate for pulmonary edema and respiratory muscle weakness.

Many tests are expensive and time-consuming. Consultation with an endocrinologist and toxicologist may be helpful for determining initial workup. Measure serum glycyrrhetinic acid (GRA) and glycyrrhizic acid (GZA) levels with enzyme-linked immunoabsorbent assay (ELISA) and high-performance liquid chromatography (HPLC). Measure the urinary GRA level with gas chromatography–mass spectrometry (GC-MS).

Ascertaining plasma renin activity and urine aldosterone level (24-h collections) is helpful; both are typically low. Determining urine cortisol levels (often elevated) and cortisol-cortisone metabolite ratios (often elevated) may be helpful.

Approach Considerations

Prehospital care consists of supportive treatment, including airway, breathing, and circulatory support (ABCs), as clinically indicated. Cardiac monitoring should be performed if clinically indicated.

Emergency department care is as follows:

Consider admitting patients with any of the following:

Consultations with an endocrinologist and a toxicologist may be helpful. Frequent assessment of hypertension and hypokalemia, as well as the need for further potassium supplements and diuretics, may be included in outpatient care.


Avoiding ingestion of natural licorice in the following settings is reasonable:

Medication Summary

The goals of pharmacotherapy are to reduce morbidity and to prevent complications. Administration of potassium-sparing diuretics that are aldosterone antagonists can counteract the cortisol activation of mineralocorticoid receptors caused by chronic licorice ingestion.

Spironolactone (Aldactone)

Clinical Context:  Spironolactone competes with aldosterone for receptor sites in distal renal tubules by increasing water and sodium chloride excretion while retaining potassium and hydrogen ions.

Triamterene (Dyrenium)

Clinical Context:  Triamterene is a potassium-sparing diuretic with relatively weak natriuretic properties. It exerts a diuretic effect on the distal renal tubule, inhibiting reabsorption of sodium in exchange for potassium and hydrogen. It increases sodium excretion and reduces the excessive loss of potassium and hydrogen associated with hydrochlorothiazide. This agent is not a competitive antagonist of mineralocorticoids; a potassium-conserving effect is observed in patients with Addison disease (ie, without aldosterone).

Class Summary

These agents may be used to correct potassium deficiency or fluid/electrolyte imbalance.


Seth Schonwald, MD, FACEP, Attending Physician, Department of Emergency Medicine, Boston Veterans Affairs Medical Center

Disclosure: Nothing to disclose.

Chief Editor

Sage W Wiener, MD, Assistant Professor, Department of Emergency Medicine, State University of New York Downstate Medical Center; Director of Medical Toxicology, Department of Emergency Medicine, Kings County Hospital Center

Disclosure: Nothing to disclose.


B Zane Horowitz, MD, FACMT Professor, Department of Emergency Medicine, Oregon Health and Sciences University; Medical Director, Oregon Poison Center; Medical Director, Alaska Poison Control System

B Zane Horowitz, MD, FACMT is a member of the following medical societies: American Academy of Clinical Toxicology and American College of Medical Toxicology

Disclosure: Nothing to disclose.

John T VanDeVoort, PharmD Regional Director of Pharmacy, Sacred Heart and St Joseph's Hospitals

John T VanDeVoort, PharmD is a member of the following medical societies: American Society of Health-System Pharmacists

Disclosure: Nothing to disclose.


  1. Isbrucker RA, Burdock GA. Risk and safety assessment on the consumption of Licorice root (Glycyrrhiza sp.), its extract and powder as a food ingredient, with emphasis on the pharmacology and toxicology of glycyrrhizin. Regul Toxicol Pharmacol. 2006 Dec. 46(3):167-92. [View Abstract]
  2. Toxicology Data Network. Licorice Extract. CASRN: 68916-91-6. ToxNet. Available at Accessed: March 14, 2019.
  3. U.S. Food and Drug Administration. Black Licorice: Trick or Treat?. Available at October 30, 2017; Accessed: March 14, 2019.
  4. Davis EA, Morris DJ. Medicinal uses of licorice through the millennia: the good and plenty of it. Mol Cell Endocrinol. 1991 Jun. 78(1-2):1-6. [View Abstract]
  5. Anderson DM, Smith WG. The antitussive activity of glycyrrhetinic acid and its derivatives. J Pharm Pharmacol. 1961 Jul. 13:396-404. [View Abstract]
  6. Krausse R, Bielenberg J, Blaschek W, Ullmann U. In vitro anti-Helicobacter pylori activity of Extractum liquiritiae, glycyrrhizin and its metabolites. J Antimicrob Chemother. 2004 Jul. 54(1):243-6. [View Abstract]
  7. Cooper H, Bhattacharya B, Verma V, McCulloch AJ, Smellie WS, Heald AH. Liquorice and soy sauce, a life-saving concoction in a patient with Addison's disease. Ann Clin Biochem. 2007 Jul. 44(Pt 4):397-9. [View Abstract]
  8. Ross EJ. Liquorice and Addison's disease. Br Med J. 1970 Jun 20. 2(5711):733. [View Abstract]
  9. Dhiman RK, Chawla YK. Herbal medicines for liver diseases. Dig Dis Sci. 2005 Oct. 50(10):1807-12. [View Abstract]
  10. Kim YW, Kang HE, Lee MG, Hwang SJ, Kim SC, Lee CH, et al. Liquiritigenin, a flavonoid aglycone from licorice, has a choleretic effect and the ability to induce hepatic transporters and phase-II enzymes. Am J Physiol Gastrointest Liver Physiol. 2009 Feb. 296(2):G372-81. [View Abstract]
  11. Shimada S, Arai T, Tamaoka A, Homma M. Liquorice-induced hypokalaemia in patients treated with Yokukansan preparations: identification of the risk factors in a retrospective cohort study. BMJ Open. 2017 Jun 15. 7 (6):e014218. [View Abstract]
  12. Foster S, Foster R, Jackson P, Song S. All sorts of tests, only one question: an unexpected cause of hypertension. BMJ Case Rep. 2017 Nov 9. 2017:[View Abstract]
  13. Carmines EL, Lemus R, Gaworski CL. Toxicologic evaluation of licorice extract as a cigarette ingredient. Food Chem Toxicol. 2005 Sep. 43(9):1303-22. [View Abstract]
  14. Farese RV Jr, Biglieri EG, Shackleton CH, Irony I, Gomez-Fontes R. Licorice-induced hypermineralocorticoidism. N Engl J Med. 1991 Oct 24. 325(17):1223-7. [View Abstract]
  15. Walker BR, Edwards CR. Licorice-induced hypertension and syndromes of apparent mineralocorticoid excess. Endocrinol Metab Clin North Am. 1994 Jun. 23(2):359-77. [View Abstract]
  16. van Uum SH. Liquorice and hypertension. Neth J Med. 2005 Apr. 63(4):119-20. [View Abstract]
  17. Palermo M, Quinkler M, Stewart PM. Apparent mineralocorticoid excess syndrome: an overview. Arq Bras Endocrinol Metabol. 2004 Oct. 48(5):687-96. [View Abstract]
  18. Khanna A, Kurtzman NA. Metabolic alkalosis. J Nephrol. 2006 Mar-Apr. 19 Suppl 9:S86-96. [View Abstract]
  19. Armanini D, Bonanni G, Palermo M. Reduction of serum testosterone in men by licorice. N Engl J Med. 1999 Oct 7. 341(15):1158. [View Abstract]
  20. Armanini D, Mattarello MJ, Fiore C, Bonanni G, Scaroni C, Sartorato P. Licorice reduces serum testosterone in healthy women. Steroids. 2004 Oct-Nov. 69(11-12):763-6. [View Abstract]
  21. Penninkilampi R, Eslick EM, Eslick GD. The association between consistent licorice ingestion, hypertension and hypokalaemia: a systematic review and meta-analysis. J Hum Hypertens. 2017 Nov. 31 (11):699-707. [View Abstract]
  22. Epstein MT, Espiner EA, Donald RA, Hughes H. Liquorice toxicity and the renin-angiotensin-aldosterone axis in man. Br Med J. 1977 Jan 22. 1(6055):209-10. [View Abstract]
  23. Biglieri EG. Spectrum of mineralocorticoid hypertension. Hypertension. 1991 Feb. 17(2):251-61. [View Abstract]
  24. Breidthardt T, Namdar M, Hess B. A hypertensive urgency induced by the continuous intake of a herbal remedy containing liquorice. J Hum Hypertens. 2006 Jun. 20(6):465-6. [View Abstract]
  25. Elinav E, Chajek-Shaul T. Licorice consumption causing severe hypokalemic paralysis. Mayo Clin Proc. 2003 Jun. 78(6):767-8. [View Abstract]
  26. Cibelli G, De Mari M, Pozio G, Lamberti P. Hypokalemic myopathy associated with liquorice ingestion. Ital J Neurol Sci. 1984 Dec. 5(4):463-6. [View Abstract]
  27. Barrella M, Lauria G, Quatrale R, Paolino E. Hypokaliemic rhabdomyolysis associated with liquorice ingestion: report of an atypical case. Ital J Neurol Sci. 1997 Aug. 18(4):217-20. [View Abstract]
  28. van den Bosch AE, van der Klooster JM, Zuidgeest DM, Ouwendijk RJ, Dees A. Severe hypokalaemic paralysis and rhabdomyolysis due to ingestion of liquorice. Neth J Med. 2005 Apr. 63(4):146-8. [View Abstract]
  29. Zenone T, Blanc Q. [Rhabdomyolysis with major hypokalemia secondary to chronic glycyrrhizic acid ingestion]. Rev Med Interne. 2009 Jan. 30(1):78-80. [View Abstract]
  30. Johns C. Glycyrrhizic acid toxicity caused by consumption of licorice candy cigars. CJEM. 2009 Jan. 11(1):94-6. [View Abstract]